Unjoni Ewropea - Rumen - EMA (European Medicines Agency)

gilead sciences ireland uc - idelalisibul - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.

Unjoni Ewropea - Rumen - EMA (European Medicines Agency)

abbvie deutschland gmbh co. kg - venetoclax - leucemie, limfocitică, cronică, celule b - agenți antineoplazici - venclyxto in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll) (see section 5. venclyxto in combination with rituximab is indicated for the treatment of adult patients with cll who have received at least one prior therapy. venclyxto monotherapy is indicated for the treatment of cll:- in the presence of 17p deletion or tp53 mutation in adult patients who are unsuitable for or have failed a b cell receptor pathway inhibitor, or- in the absence of 17p deletion or tp53 mutation in adult patients who have failed both chemoimmunotherapy and a b-cell receptor pathway inhibitor. venclyxto in combination with a hypomethylating agent is indicated for the treatment of adult patients with newly  diagnosed acute myeloid leukaemia (aml) who are ineligible for intensive chemotherapy.

Rumanija - Rumen - ANMDM (Agenția Națională a Medicamentului și a Dispozitivelor Medicale din România)

chiesi farmaceutici s.p.a. - italia - combinatii (beclometasonum+formoterolum) - pulb. de inhal. - 200micrograme/6micrograme - adrenergice inhalante adrenergice si alte med. pt. trat. bolilor obstructive c.r

Maldova - Rumen - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

johnson & johnson srl - risperidonum - pulbere si solvent pentru suspensie injectabila cu eliberare prelungita - 37,5 mg

Maldova - Rumen - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

johnson & johnson srl - risperidonum - pulbere si solvent pentru suspensie injectabila cu eliberare prelungita - 50 mg

Maldova - Rumen - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

johnson & johnson srl - risperidonum - pulbere si solvent pentru suspensie injectabila cu eliberare prelungita - 25 mg

Maldova - Rumen - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

sichuan kelun pharmaceutical co., ltd. - metronidazolum - soluţie perfuzabilă - 5 mg/1 ml

Maldova - Rumen - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

compania farmaceutică "zdorovie" srl - phenindionum - comprimate - 30 mg

Maldova - Rumen - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

uzina experimentală gnŢls srl - amitriptylinum - comprimate filmate - 25 mg

Maldova - Rumen - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

sichuan kelun pharmaceutical co., ltd. - metronidazolum - soluţie perfuzabilă - 5 mg/ml